Viewing nowLobakay Tablet 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
KS Pharmaceutical Co., Ltd.

MFDS item code 201908152 · Approved 2019.11.28 · Insurance code 059000060
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct therapy for patients with hypercholesterolemia and dyslipidemia when dietary control and exercise are insufficient, especially effective for familial hypercholesterolemia and mixed dyslipidemia. It also helps reduce total cholesterol and LDL cholesterol levels in high-risk patients with cardiovascular disease risk factors, aiding in the slowing of atherosclerosis progression. It is applicable to pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia, used alongside dietary therapy to control cholesterol levels. Additionally, it is used as an adjunct to dietary therapy for patients with primary dysbetalipoproteinemia and is effective in reducing cardiovascular disease risk. Particularly in middle-aged individuals with high-sensitivity C-reactive protein levels, this medication contributes to lowering the risk of stroke, myocardial infarction, and arterial revascularization procedures. This medication improves cardiovascular health and effectively treats dyslipidemia.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 mg daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this drug is contraindicated in some of these patients.
Age 10 years to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For example, it should not be given to patients who are allergic to any component of this medication, those with severely impaired liver function, patients with muscle disorders, and those with severe renal impairment. Additionally, pregnant or breastfeeding women and women of childbearing age who do not use appropriate contraception should not use this medication. This medication can affect muscles, so caution is necessary for patients at high risk of muscle pain or myopathy. Especially at high doses, the risk of muscle damage increases, making dose adjustment important. Patients with liver dysfunction or those who consume excessive alcohol should have liver function tests before taking this medication and periodically monitor liver function during treatment. During treatment with this medication, if muscle pain, muscle weakness, or unexplainable fatigue or fever appear, inform medical personnel immediately. If these symptoms are severe or if blood tests indicate significantly elevated muscle damage markers, discontinuation of the medication may be warranted. This medication can interact with certain drugs when taken together, so if other medications are being taken, healthcare providers must be informed. Particularly, caution is needed when used in combination with drugs that increase the risk of muscle toxicity. Pregnant or breastfeeding women should not use this medication, and women of childbearing age should use appropriate contraception methods. In cases of overdose, there is no specific antidote available, so treatment should be symptomatic and liver function and muscle damage markers should be tested. This medication does not significantly impact driving or machinery operation abilities but caution is needed due to potential dizziness. Finally, during treatment with this medication, liver function and muscle health should be regularly monitored, and if abnormal symptoms appear, healthcare providers should be consulted immediately.
Hypersensitivity, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, muscle pain, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, it is recommended to store the medication at room temperature between 1°C and 30°C. This helps maintain the drug's effectiveness over time.
Pink, round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
KS Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.